OCT 27, 2020 8:00 AM PDT

A Super Sensitive Alzheimer's Test Powered by Nanozymes

WRITTEN BY: Tara Fernandez

Simple tasks are now uphill struggles, social situations aren’t fun, and the house keys are missing again. By the time these symptoms of Alzheimer’s disease begin to take a toll on a patient’s quality of life, the damage is done — there is already severe neurodegeneration. 

Scientists at Washington State University (WSU) have revealed a diagnostic innovation for Alzheimer’s that is 10 times more powerful than existing technologies, which could make it possible for doctors to detect the onset of the disease much earlier.

Existing diagnostic methods rely heavily on brain imaging technologies such as magnetic resonance imaging, or MRI, and CT scans. Here, physicians are looking for structural changes in the neuroanatomy, particularly shrinkage in the temporal and parietal lobes of the brain. Another (more painful) option is to take a sample of spinal fluid and analyze it for the presence of beta-amyloid biomarkers.

The team at WSU has developed a single-atom nanozyme: a synthetic enzyme that detects the presence of Alzheimer’s biomarkers with unprecedented sensitivity. These nanostructures, composed of carbon nanotubes coated with iron atoms, can detect trace amounts of beta-amyloid proteins, at levels 10 times lower than if conventional enzyme-linked immunosorbent assays (ELISA) were used. With this level of sensitivity, Alzheimer’s biomarkers could be picked up in blood samples from patients without the need for spinal taps.

“The nanozyme based on a single-atom catalyst that we created has a similar structure as a natural enzyme with remarkable enzyme-like activity and paved the way for detecting the Alzheimer’s Disease biomarker,” said Professor Dan (Annie) Du from WSU’s School of Mechanical and Materials Engineering who led the study. These novel molecules are also superior to ELISAs that use naturally-derived enzymes in that they are more cost-effective and have a much longer shelf life.

The team plans to continue the study by validating the newly-developed assay using blood samples from Alzheimer’s patients and healthy controls.

“This shows great potential for the early-stage diagnosis of Alzheimer’s Disease,” commented Du. 

Sources: Washington State University, Research.


 

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
MAY 06, 2021
Clinical & Molecular DX
Sweat Sensor Can Tell If a Storm's Coming
MAY 06, 2021
Sweat Sensor Can Tell If a Storm's Coming
A surge of pro-inflammatory cytokines, intense, and sustained inflammation leading to organ damage and a high risk of de ...
JUN 02, 2021
Genetics & Genomics
A Genetic Form of ALS is Discovered
JUN 02, 2021
A Genetic Form of ALS is Discovered
Some medical mysteries have become much easier to solve because of advanced genetic techniques that have enabled researc ...
JUN 04, 2021
Clinical & Molecular DX
Tiny Bone Marrow Models Help Tailor Treatments for Platelet Disorder Patients
JUN 04, 2021
Tiny Bone Marrow Models Help Tailor Treatments for Platelet Disorder Patients
  Scientists have developed miniaturized 3-dimensional bone marrow models that could help physicians to predict whi ...
JUL 06, 2021
Clinical & Molecular DX
Undiagnosed Dementia Much More Prevalent Than Previously Thought
JUL 06, 2021
Undiagnosed Dementia Much More Prevalent Than Previously Thought
An analysis of data from the Health and Retirement Study has yielded a startling revelation: 91 percent of people experi ...
JUL 19, 2021
Cardiology
Immune Proteins & Blood Clots May be Connected to Psychosis Development
JUL 19, 2021
Immune Proteins & Blood Clots May be Connected to Psychosis Development
Researchers are pointing out the associations between blood clotting disruptions and the front line immune system, and t ...
SEP 16, 2021
Clinical & Molecular DX
Your T-Shirt Could Soon Tell You if Your Heart Is Ok
SEP 16, 2021
Your T-Shirt Could Soon Tell You if Your Heart Is Ok
Forget uncomfortable chest straps or clunky wristbands—thanks to a new innovation in nanotechnology, your t-shirt ...
Loading Comments...